For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for SLU-PP-332 Capsules

Capsule comparison

SLU-PP-332 Capsules prices

Compare SLU-PP-332 Capsules listings by strength, selection and supplier. Inspect the original source behind each price.

2suppliers represented
8source-linked listings
4strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 0.25 mg2 suppliers · Pack counts: 60
  • 1 mg2 suppliers · Pack counts: 60
  • 20 mg2 suppliers · Pack counts: 60
  • 50 mg2 suppliers · Pack counts: 60

Reported quantities in this family: 60. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.

Suppliers with SLU-PP-332 Capsules listings

2 profiles

Sources and comparison limits

8 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more capsule listings

Browse all products

FROM PEPTIDES CALCULATOR

About SLU-PP-332

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

SLU-PP-332 is a synthetic small molecule rather than a peptide, developed in Thomas Burris's medicinal chemistry laboratory at Saint Louis University as the first usable agonist of all three estrogen-related receptors. Because those receptors sit downstream of PGC-1 alpha and control mitochondrial biogenesis and fatty acid oxidation, the compound switches on much of the gene programme that aerobic training switches on, which is why it is described as an exercise mimetic. Every published study is in mice or cell lines: no human trial has been registered, there is no FDA approval or investigational application, and the compound does not appear on the FDA list of bulk substances that pharmacies may compound. It reached the research-chemical market after a 2023 conference presentation and is sold as oral tablets, capsules and occasional injectable preparations, despite the originating laboratory reporting that the parent compound lacks oral bioavailability.

Formula
C18 H14 N2 O2
Molar mass
290.3 g/mol
CAS number
303760-60-3

Research evidence described in the source

Not graded

Research Status & Administration Notes

Important context about current evidence and why no dosing guide is presented

Not graded

Mechanism of Action

How SLU-PP-332 is thought to mimic parts of the exercise response

Not graded

Preclinical Metabolic Research

Findings from obesity, glucose control, and fat metabolism models

Not graded

Mitochondrial Function, Endurance & Exercise Mimicry

Why SLU-PP-332 is often described as an exercise mimetic

Limitations noted in the source

  • Safety Concerns & Translational Barriers: What still limits translation from animal research to human use
  • Future Research: Where the field is likely heading next
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.